Enalare Therapeutics

About:

Enalare Therapeutics is a clinical stage biopharmaceutical company dedicated to developing novel therapies.

Website: https://enalare.com/

Top Investors: NJEDA, National Institute on Drug Abuse (NIDA), Biomedical Advanced Research and Development Authority (BARDA), Eagle Pharmaceuticals

Description:

Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from acute respiratory and critical care conditions including respiratory depression caused by drug overdose, post-surgery, and pathogens.

Total Funding Amount:

$73.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Naples, Florida, United States

Founded Date:

2019-01-01

Contact Email:

Contact(AT)enalare.com

Founders:

Joseph Pergolizzi

Number of Employees:

11-50

Last Funding Date:

2024-09-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai